Olivier J. David
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial.
Journal: Nature medicine
Published: June 16, 2025
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).
Journal: Clinical pharmacokinetics
Published: November 01, 2022
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.
Journal: EMBO molecular medicine
Published: September 19, 2018
Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod.
Journal: Clinical pharmacology in drug development
Published: November 04, 2016
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.
Journal: Neurogastroenterology and motility
Published: October 09, 2016
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: June 30, 2016
Pharmacokinetics of fingolimod and metabolites in subjects with severe renal impairment: An open-label, single-dose, parallel-group study.
Journal: International journal of clinical pharmacology and therapeutics
Published: August 27, 2015
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function and macular thickness in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: November 25, 2013
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Journal: International journal of clinical pharmacology and therapeutics
Published: June 28, 2012
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Journal: Clinical pharmacology in drug development
Published: February 14, 2012
Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study.
Journal: Journal of clinical pharmacology
Published: December 17, 2011
Last Updated: 09/26/2026